Related Experiment Video
Updated: Mar 19, 2026

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
Three New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage Therapy
Marion Dalmasso1,2, Ronan Strain1,2, Horst Neve3
1School of Microbiology, University College Cork, Cork, Ireland.
Abstract:
With the emergence of multi-drug resistant bacteria the use of bacteriophages (phages) is gaining renewed interest as promising anti-microbial agents. The aim of this study was to isolate and characterize phages from human fecal samples. Three new coliphages, ɸAPCEc01, ɸAPCEc02 and ɸAPCEc03, were isolated. Their phenotypic and genomic characteristics, and lytic activity against biofilm, and in combination with ciprofloxacin, were investigated. All three phages reduced the growth of E. coli strain DPC6051 at multiplicity of infection (MOI) between 10-3 and 105. A cocktail of all three phages completely inhibited the growth of E. coli. The phage cocktail also reduced biofilm formation and prevented the emergence of phage-resistant mutants which occurred with single phage. When combined with ciprofloxacin, phage alone or in cocktail inhibited the growth of E. coli and prevented the emergence of resistant mutants. These three new phages are promising biocontrol agents for E. coli infections.
Insights
New bacteriophages (phages) show promise against multi-drug resistant bacteria. A phage cocktail effectively inhibited E. coli growth, reduced biofilms, and prevented resistance, offering a potential biocontrol strategy.
Area of Science:
- Microbiology
- Bacteriophage Therapy
- Antimicrobial Resistance
Background:
- Multi-drug resistant bacteria pose a significant global health threat.
- Bacteriophages (phages) are viruses that infect bacteria and are being re-evaluated as antimicrobial agents.
- Phage therapy offers a potential alternative to conventional antibiotics.
Purpose of the Study:
- To isolate and characterize novel bacteriophages from human fecal samples.
- To evaluate the lytic activity of isolated phages against E. coli.
- To assess the efficacy of phages in combination with ciprofloxacin and their ability to prevent resistance.
Main Methods:
- Isolation of coliphages from human fecal samples.
- Phenotypic and genomic characterization of isolated phages.
- Assessment of lytic activity against E. coli biofilms and in combination with ciprofloxacin.
Main Results:
- Three novel coliphages (ɸAPCEc01, ɸAPCEc02, ɸAPCEc03) were isolated.
- A phage cocktail completely inhibited E. coli growth and reduced biofilm formation.
- The phage cocktail prevented the emergence of phage-resistant mutants, unlike single phages.
- Combination therapy with ciprofloxacin and phages inhibited E. coli and prevented resistance.
Conclusions:
- The isolated bacteriophages demonstrate significant lytic activity against E. coli.
- A phage cocktail is effective in controlling E. coli growth and biofilms.
- Phage therapy, alone or in combination with antibiotics, is a promising strategy to combat E. coli infections and prevent resistance.
More Related Videos
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
DNA Bacteriophages
Bacterial Gastroenteritis
Viral Replication: Lytic Cycle
Human Virome

